Global Biodefense Market Segment by Regions, Type, Regional Analysis and Outlook
Posted by Deeksha on March 13th, 2019
A newly compiled business intelligent report, titled “Global Biodefense Market” 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024 has been publicized to the vast archive of Market Research Hub (MRH) online repository. The study revolves around the analysis of Biodefense Market, covering key industry developments and market opportunity map during the mentioned forecast period. This report further conveys quantitative & qualitative analysis on the concerned market, providing a 360 view on current and future market prospects. As the report proceeds, information regarding the prominent trends as well as opportunities in the key geographical segments have also been explained, thus enabling companies to be able to make region-specific strategies for gaining competitive lead.
Get Sample Copy of this Report@ https://www.marketresearchhub.com/enquiry.php?type=S&repid=2169073
Biodefense market refers to the pharmaceuticals, vaccines and antibodies applied in the treatment of a wide range of infectious diseases, whether those diseases emerge naturally or are deliberately introduced as an act of bioterrorism. Biodefense products generally defense against anthrax, smallpox, botulism, radiation/nuclear disasters and other disasters.
In the wake of the 2001 anthrax attacks, the U.S. government set out on a bold path to improve the countrys preparedness for bioterrorism by developing and stockpiling new drugs and vaccines to protect Americans from health emergencies. Since 2004, the US government has provided assistance in the development and manufacturing of products in order to maintain its Strategic National Stockpile (SNS) to counter any bioterror attack.
Scope of the Report:
USA is still the largest supplier and consumption market due to the highly developed pharmaceuticals technology and increased awareness of the threat of global terror activity. In 2015, USA enjoyed over 80% consumption market.
By type, Anthrax defense products are most used with market share over 40%, followed by Smallpox defense products and Botulism defense products separately with market share about 30% and 14%. In addition, other diseases like Ebola and Marburg are occupying more and more market share.
In this year, the international situation is not complex, and partial conflict is frequent. Terrorist organization like IS was just making terrorist activity in Paris, which largely increased peoples awareness of the threat of terrorist activity. As a result, the biodefense industry is expecting in the next years.
The worldwide market for Biodefense is expected to grow at a CAGR of roughly 8.5% over the next five years, will reach 1390 million US$ in 2024, from 850 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Biodefense in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Emergent Biosolutions
Hytest
GSK
Sanofi
PharmAthene
Bavarian Nordic
SIGA Technologies
Arbutus Biopharma
DynPort Vaccine
Xoma Corporation
Ichor Medical Systems
Aeolus Pharmaceuticals
Achaogen
Elusys Therapeutics
Dynavax Technologies
Cleveland BioLabs
Soligenix
Alnylam Pharmaceuticals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Anthrax
Smallpox
Botulism
Radiation/Nuclear
Others
Market Segment by Applications, can be divided into
US Military Market
US Civilian Market
Non - US Market
Request Report TOC @ https://www.marketresearchhub.com/report/global-biodefense-market-2019-by-manufacturers-regions-type-and-application-forecast-to-2024-report.html
Table of Contents
1 Market Overview
1.1 Biodefense Introduction
1.2 Market Analysis by Type
1.2.1 Anthrax
1.2.2 Smallpox
1.2.3 Botulism
1.2.4 Radiation/Nuclear
1.2.5 Others
1.3 Market Analysis by Applications
1.3.1 US Military Market
1.3.2 US Civilian Market
1.3.3 Non - US Market
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
Continued….......@@#
